Speaking from the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European School of Haematology (ESH), Stéphane de Botton, MD, PhD of the Gustave Roussy Institute, Villejuif, France, talks about his experience of working with a smaller company of researchers and their medical team during drug development. Dr de Botton compared this to working for bigger pharmaceutical companies, where, in his experience, collaboration tends to be different.
